维普中文期刊产品整合服务
11篇 您的检索式:作者名="LAFERL H"
    题名 作者 年代 出处 被引量
1A randomized, prospective trial of ribavirin 400 rag/day versus 800 mg/day in combination with peg interferon alfa-2a in hepatitis C virus genotypes2 and 3 显示文摘Ferenei P Laferl H Scherzer TM 2008Hepatology2008,47,6:1
2Randomized comparison of 12 or 24 weeks of peg interferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2 /3 infection 显示文摘Ferenci P Brunner H Laferl H 2008Hepatology2008,47,6:1
3Acute encephalopathy associated with influenza A virus infection显示文摘Steininger C Popow-Kraupp T Laferl H 2003Clin Infect Dis2003,36,5:1
4Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response显示文摘FERENCI P LAFERL H SCHERZER T M 2008Gastroenterology2008,135,2:1
5Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response显示文摘Ferenci P Laferl H Scherzer TM 2010Gastroenterology2010,138,2:1
6Peginterferon alfa-2a and riba- virin for 24 weeks in hepatitis C type 1 and 4 patients with rapid viro- logical response显示文摘Ferenci P Laferl H Scherzer TM 2008Gastroenterology2008,135,2:1
7A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3显示文摘Ferenci P Laferl H Scherzer TM 2008Hepatology2008,47,6:1
8Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection 显示文摘Ferenci P Brunner H Laferl H 2008Hepatology2008,47,6:1
9Rapid reversible co ma with intravenous gamma hydroxybutyrate in a moxifloxatin treated patient显示文摘Koehler G Haimann A Laferl H 2005Clin Drug Investig2005,25,8:1
10Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response显示文摘Ferenci P Laferl H Scherzer TM 2008Gastroenterology2008,135,2:1
11Rapid reversible coma with intravenous gamma-hydroxybutyrate in a moxifloxacin-treated patient显示文摘Koehler G Haimann A Laferl H 2005Clin Drug Investig2005,25,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费